Cardinal Health Inc.
Cardinal Health Completes Public Offering of $1 Billion in Notes for Solaris Health Acquisition
Summary
On August 27, 2025, Cardinal Health, Inc. completed a public offering of $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035. The net proceeds from the sale of these Notes will be used to fund a portion of the consideration payable in connection with the proposed acquisition of Solaris Health. If the acquisition is not consummated by August 12, 2026, or if the company decides not to pursue the acquisition, the company will redeem the Notes at 101% of the aggregate principal amount plus accrued interest.
Profitelligence Alerts
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement